EVALUATION OF THE IMPACT OF CURRENT TREATMENT ON SERUM URATE PROFILE, GOUT FLARES AND TOPHI IN PATIENTS WITH GOUT IN FRANCE, GERMANY, UNITED KINGDOM AND THE UNITED STATES

被引：3
|
作者：
Nuevo, J. [1 ]
Nyberg, F. [2 ]
Horne, L. [3 ]
Morlock, R. [4 ]
Storgard, C. [4 ]
Aiyer, L. [4 ]
Hines, D. M. [5 ]
Ansolabehere, X. [6 ]
Chevalier, P. [7 ]
机构：
[1] AstraZeneca, Madrid, Spain
[2] AstraZeneca, Molndal, Sweden
[3] AstraZeneca, Wilmington, DE USA
[4] Ardea Biosci Inc, San Diego, CA USA
[5] IMS Hlth, Alexandria, VA USA
[6] IMS Hlth, Paris, France
[7] IMS Hlth, Vilvoorde, Belgium
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2015年 / 74卷
关键词：
D O I：
10.1136/annrheumdis-2015-eular.5007
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
FRI0343
引用
收藏
页码：549 / 550
页数：2
相关论文
共 49 条
  • [31] The impact of remission on healthcare resource utilisation and costs amongst patients with inflammatory bowel disease in France, Germany, Italy, Spain, and the United Kingdom
    Patel, K. V.
    Salmon, P.
    Marin-Jimenez, I.
    Thessen, M.
    Kligys, K.
    Sharma, D.
    Gonzalez, Y. Sanchez
    Kershaw, J.
    JOURNAL OF CROHNS & COLITIS, 2023, 17 : 544 - 546
  • [32] Impact of disease location on burden of illness in patients with moderate-severe Crohn's disease: A real-world survey in the United States, France, Germany, Italy, Spain, and United Kingdom (5EU)
    Sikirica, M.
    Lynch, J.
    Kershaw, J.
    Lukanova, R.
    Baker, S.
    Milligan, G.
    JOURNAL OF CROHNS & COLITIS, 2022, 16 : I230 - I230
  • [33] CHARACTERISTICS AND TREATMENT PATTERNS FOR NON-METASTATIC CASTRATION RESISTANT PROSTATE CANCER (NMCRPC) PATIENTS IN GERMANY, FRANCE, AND UNITED KINGDOM (UK)
    Shah, R.
    Ikeme, S.
    Botteman, M.
    Waldeck, R.
    VALUE IN HEALTH, 2019, 22 : S85 - S85
  • [34] IMPACT ON HEALTHCARE RESOURCE UTILIZATION AND INDIRECT COSTS AMONG INDIVIDUALS WITH MIGRAINE AND PREVENTIVE TREATMENT FAILURE IN FRANCE, GERMANY, ITALY, SPAIN AND UNITED KINGDOM
    Buse, D. C.
    Pozo-Rosich, P.
    Reuter, U.
    Balkaran, B. L.
    Way, N.
    Jauregui, A.
    Gandhi, P.
    Parikh, M.
    Dupont-Benjamin, L.
    VALUE IN HEALTH, 2022, 25 (12) : S92 - S92
  • [35] Use of perioperative treatment (tx) among patients (pts) undergoing radical resection (RR) for muscle-invasive urothelial cancer (MIUC) in France, Germany, Italy, Spain, the United Kingdom, the United States, Canada, China, and Japan.
    Broughton, Edward I.
    Gschwend, Juergen E.
    Witjes, J. Alfred
    Berry, Mia
    Kostikas, Michael
    Montgomery, Rachel
    Lambert, Annabel
    Teitsson, Siguroli
    Milloy, Neil
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (06)
  • [36] Treatment preferences among triple-class exposed patients with relapsed/refractory multiple myeloma in the United States (US), United Kingdom (UK), and Germany (DE): a discrete choice experiment
    Rodriguez-Otero, Paula
    Michaels-Igbokwe, Christine
    Collacott, Hannah
    Braverman, Julia
    Marshall, Thomas
    Tinel, Antoine
    Dhanda, Devender
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S209 - S209
  • [37] A Retrospective Chart Review of Treatment Patterns and Overall Survival among a Cohort of Patients with Relapsed/Refractory Mycosis Fungoides in France, Germany, Italy, Spain and the United Kingdom
    Assaf, Chalid
    Illidge, Timothy M.
    Waser, Nathalie
    He, Mary
    Li, Tina
    Zomas, Athanasios
    Bent-Ennakhil, Nawal
    Little, Meredith
    Ortiz-Romero, Pablo L.
    Pimpinelli, Nicola
    Dalal, Mehul
    Bagot, Martine
    CANCERS, 2023, 15 (23)
  • [38] Safety and efficacy of verinurad, a selective URAT1 inhibitor, for the treatment of patients with gout and/or asymptomatic hyperuricemia in the United States and Japan: Findings from two phase II trials
    Fitz-Patrick, David
    Roberson, Kent
    Niwa, Kiyoshi
    Fujimura, Takabumi
    Mori, Koji
    Hall, Jesse
    Yan, Xiaohong
    Shen, Zancong
    Liu, Sha
    Ito, Yasushi
    Baumgartner, Scott
    MODERN RHEUMATOLOGY, 2019, 29 (06) : 1042 - 1052
  • [39] Impact of Preventive Medication Failure in Quality of Life and Functioning Among Individuals With Migraine and Preventive Treatment Failure in France, Germany, Italy, and Spain and the United Kingdom: Need for Effective Preventive Treatment
    Buse, Dawn C.
    Rosich, Patricia P.
    Reuter, Uwe
    Balkaran, Bridget L.
    Way, Nate
    Jauregui, Adam
    Gandhi, Pranav
    Parikh, Mousam
    Dupont-Benjamin, Laure
    CEPHALALGIA, 2022, 42 (1_SUPPL) : 16 - 17
  • [40] Persistent burden of disease in patients with Crohn's disease treated with biologic therapy: results from a real-world survey in the United States (US), France, Germany, Italy, Spain, and United Kingdom (5EU)
    Sikirica, M.
    Lynch, J.
    Kershaw, J.
    Lukanova, R.
    Baker, S.
    Milligan, G.
    JOURNAL OF CROHNS & COLITIS, 2022, 16 : I292 - I293
12345